Last reviewed · How we verify
Thrombosis in Heparin Induced Thrombocytopenia
Approved treatments
- Argatroban · Hikma Pharm Co Ltd
Argatroban works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process. - Refludan
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Thrombosis in Heparin Induced Thrombocytopenia patent landscape — cliff calendar, originator estates, attackable patents
- Thrombosis in Heparin Induced Thrombocytopenia treatment landscape brief
- Thrombosis in Heparin Induced Thrombocytopenia treatment updates RSS
Frequently asked questions about Thrombosis in Heparin Induced Thrombocytopenia
What drugs treat Thrombosis in Heparin Induced Thrombocytopenia?
Tracked treatments include Argatroban, Refludan.
What is the treatment for Thrombosis in Heparin Induced Thrombocytopenia?
Standard treatment for Thrombosis in Heparin Induced Thrombocytopenia includes Argatroban, Refludan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Thrombosis in Heparin Induced Thrombocytopenia patent cliff · Thrombosis in Heparin Induced Thrombocytopenia CI report
- Treatment: Argatroban · Hikma Pharm Co Ltd
- Treatment: Refludan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing